Moderna shares fell over 4% after the FDA signaled stricter vaccine approval rules, raising concerns about potential delays ...
Vinay Prasad, the head of the US FDA's Center for Biologics Evaluations and Research which oversees vaccines, said that future vaccine approvals will face stricter standards in light of the deaths of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback